Home LiteratureArticle Details
PMID: 14711881 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Phenotypic clustering in MPZ mutations.

Brain : a journal of neurology ·Vol. 127 ·No. Pt 2 ·2004-02-00 ·Pages 371-84

Shy ME, Jáni A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J

Abstract

Myelin protein zero (MPZ) is a member of the immunoglobulin gene superfamily with single extracellular, transmembrane and cytoplasmic domains. Homotypic interactions between extracellular domains of MPZ adhere adjacent myelin wraps to each other. MPZ is also necessary for myelin compaction since mice which lack MPZ develop severe dysmyelinating neuropathies in which compaction is dramatically disrupted. MPZ mutations in humans cause the inherited demyelinating neuropathy CMT1B. Some mutations cause the severe neuropathies of infancy designated as Dejerine-Sottas disease, while others cause a 'classical' Charcot-Marie-Tooth (CMT) disease Type 1B (CMT1B) phenotype with normal early milestones but development of disability during the first two decades of life. Still other mutations cause a neuropathy that presents in adults, with normal nerve conduction velocities, designated as a 'CMT2' form of CMT1B. To correlate the phenotype of patients with MPZ mutations with their genotype, we identified and evaluated 13 patients from 12 different families with eight different MPZ mutations. In addition, we re-analysed the clinical data from 64 cases of CMT1B from the literature. Contrary to our expectations, we found that most patients presented with either an early onset neuropathy with signs and symptoms prior to the onset of walking or a late onset neuropathy with signs and symptoms at around age 40 years. Only occasional patients presented with a 'classical' CMT phenotype. Correlation of specific MPZ mutations with their phenotypes demonstrated that addition of either a charged amino acid or altering a cysteine residue in the extracellular domain caused a severe early onset neuropathy. Severe neuropathy was also caused by truncation of the cytoplasmic domain or alteration of an evolutionarily conserved amino acid. Taken together, these data suggest that early onset neuropathy is caused by MPZ mutations that significantly disrupt the tertiary structure of MPZ and thus interfere with MPZ-mediated adhesion and myelin compaction. In contrast, late onset neuropathy is caused by mutations that more subtly alter myelin structure and which probably disrupt Schwann cell-axonal interactions.

MeSH Terms
Adult Age of Onset Aged Amino Acid Sequence Child, Preschool Demyelinating Diseases/genetics,physiopathology Female Hereditary Sensory and Motor Neuropathy/genetics,physiopathology Humans Male Middle Aged Molecular Sequence Data Mutation Mutation, Missense Myelin P0 Protein/genetics Neural Conduction Open Reading Frames/genetics Phenotype Protein Structure, Secondary/genetics
Chemicals
Myelin P0 Protein
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Shy Michael E
Department of Neurology, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, USA. m.shy@wayne.edu
Jáni Agnes
Krajewski Karen
Grandis Marina
Lewis Richard A
Li Jun
Shy Rosemary R
Balsamo Janne
Lilien Jack
Garbern James Y
Kamholz John
Article Info
Journal
Brain : a journal of neurology
Abbr.
Brain
ISSN
0006-8950
Published
2004-02-00
Epub
2004-00-07
Pages
371-84
Language
English
Region
England
NLM ID
0372537
Subset
IM
Grants
NINDS NIH HHS · R01 NS41319A · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com